Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Effect of Baduanjin Exercise on Pain, Fatigue, and Quality of Recovery After Abdominal Surgery

3 novembre 2026 mis à jour par: Niran Çoban, University of Yalova

The Effect of Baduanjin Exercise on Pain, Fatigue, and Quality of Recovery in Patients Undergoing Abdominal Surgery: A Randomized Controlled Trial

This randomized controlled trial aims to evaluate the effects of Baduanjin exercise on pain, fatigue, fatigue severity, and quality of recovery in patients undergoing abdominal surgery.

A total of 60 participants will be randomly assigned to an intervention group or a control group. Before surgery, participants in the intervention group will receive instruction in Baduanjin exercises and perform the exercises once to learn the technique. After hospital discharge, they will continue the Baduanjin exercise program three days per week for six weeks. Participants in the control group will receive standard hospital care without Baduanjin exercise.

At the end of weeks 3 and 6, pain, fatigue, fatigue severity, and quality of recovery will be assessed using the Visual Analog Scale (VAS), Fatigue Scale, Fatigue Severity Scale, and Quality of Recovery-40 (QoR-40), respectively. Outcomes will be compared between the intervention and control groups.

Aperçu de l'étude

Statut

Pas encore de recrutement

Intervention / Traitement

Description détaillée

This study aims to evaluate the effects of Baduanjin exercise on pain, fatigue, fatigue severity, and quality of recovery in patients undergoing abdominal surgery. The study is planned as a randomized, controlled, pretest-posttest experimental study involving 60 patients undergoing abdominal surgery at Gümüşhane State Hospital, Türkiye. Participants will be randomly assigned to an intervention group (n=30) or a control group (n=30). Before surgery, participants in the intervention group will be taught how to perform Baduanjin exercises and will perform the exercises once under instruction to learn the technique. After hospital discharge, participants will continue the Baduanjin exercise program three days per week for six weeks. Participants in the control group will receive standard hospital care without Baduanjin exercise. At the end of weeks 3 and 6, outcomes will be assessed in both groups using the Visual Analog Scale (VAS) to measure pain intensity, the Fatigue Scale to assess fatigue, the Fatigue Severity Scale to assess fatigue severity, and the Quality of Recovery-40 (QoR-40) questionnaire to evaluate quality of recovery. The results will be compared between the intervention and control groups to determine the effects of the Baduanjin exercise program on pain, fatigue, fatigue severity, and quality of recovery following abdominal surgery.

Type d'étude

Interventionnel

Inscription (Estimé)

60

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Sauvegarde des contacts de l'étude

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 70 ans (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Patients aged 18 years and older and younger than 70 years.
  • Patients undergoing abdominal surgery.
  • Patients who voluntarily agree to participate in the study and provide informed consent.
  • Patients with a body mass index (BMI) below 40 kg/m².
  • Patients with a Standardized Mini-Mental State Examination score of 24 or higher.
  • Patients who are able to read and write.

Exclusion Criteria:

  • Patients with communication or comprehension difficulties.
  • Patients who receive sedation.
  • Patients who have difficulty understanding or speaking Turkish.
  • Patients with a psychiatric disorder who are receiving medication.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Soins de soutien
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Aucune intervention: Standart care

Participants in this group will receive standard hospital care without Baduanjin exercise. Pain, fatigue, fatigue severity, and quality of recovery will be assessed at the end of weeks 3 and 6 using the Visual Analog Scale (VAS), Fatigue Scale, Fatigue Severity Scale, and Quality of Recovery-40 (QoR-40), respectively.

Expérimental: Baduanjin Exercise Group

Participants in this group will receive instruction in Baduanjin exercises before surgery and will perform the exercises once under instruction to learn the technique. After hospital discharge, participants will continue the Baduanjin exercise program three days per week for six weeks. Pain, fatigue, fatigue severity, and quality of recovery will be assessed at the end of weeks 3 and 6 using the Visual Analog Scale (VAS), Fatigue Scale, Fatigue Severity Scale, and Quality of Recovery-40 (QoR-40), respectively.

Participants in the intervention group will be taught Baduanjin exercises before surgery and will perform the exercises once under instruction to learn the technique. After hospital discharge, participants will continue the Baduanjin exercise program three days per week for six weeks. Pain, fatigue, fatigue severity, and quality of recovery will be assessed at the end of weeks 3 and 6 using the Visual Analog Scale (VAS), Fatigue Scale, Fatigue Severity Scale, and Quality of Recovery-40 (QoR-40), respectively.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
The Effect of Baduanjin on Pain
Délai: At the end of weeks 3 and 6 after hospital discharge.

Visual Analog Scale (VAS): The Visual Analog Scale (VAS) is a commonly used tool for assessing pain. It consists of a 10-cm (100-mm) line ranging from 0 (no pain) to 10 (worst imaginable pain). In this study, the VAS will be used to assess pain in patients undergoing abdominal surgery at the end of weeks 3 and 6 after hospital discharge to evaluate the effect of Baduanjin exercise on pain.

At the end of weeks 3 and 6 after hospital discharge.
The Effect of Baduanjin on Fatigue
Délai: At the end of weeks 3 and 6 after hospital discharge.

Fatigue Scale (FS): The Fatigue Scale was developed by Beurskens et al. in 2000 to assess chronic fatigue. The scale consists of 20 items and evaluates fatigue over the previous two weeks across four dimensions: subjective fatigue perception, concentration, motivation, and physical activity. The Turkish version was validated by Ergin et al. in 2009. The total score ranges from 20 to 140, with higher scores indicating greater chronic fatigue. In this study, the Fatigue Scale will be used to assess fatigue in patients undergoing abdominal surgery at the end of weeks 3 and 6 after hospital discharge to evaluate the effect of Baduanjin exercise on fatigue.

At the end of weeks 3 and 6 after hospital discharge.
The Effect of Baduanjin Exercise on Fatigue Severity
Délai: At the end of weeks 3 and 6 after hospital discharge.

Fatigue Severity Scale (FSS): The Fatigue Severity Scale was developed by Krupp et al. in 1989 to assess fatigue severity, initially in patients with multiple sclerosis and systemic lupus erythematosus. It consists of nine items assessing the subjective severity of fatigue during the previous week. Each item is rated on a seven-point scale, and the total score is calculated as the arithmetic mean of the item scores. Higher scores indicate greater fatigue severity, and a score of approximately 4 or above generally suggests substantial fatigue. The Turkish validity and reliability study was conducted by Gencay Can et al. in 2012. In this study, the Fatigue Severity Scale will be used to assess fatigue severity in patients undergoing abdominal surgery at the end of weeks 3 and 6 after hospital discharge to evaluate the effect of Baduanjin exercise on fatigue severity.

At the end of weeks 3 and 6 after hospital discharge.
The Effect of Baduanjin Exercise on Quality of Recovery
Délai: At the end of weeks 3 and 6 after hospital discharge.

Quality of Recovery-40 (QoR-40): The Quality of Recovery-40 (QoR-40) was developed by Myles et al. in 2000 and its Turkish validity and reliability were evaluated by Karaman et al. in 2014. The questionnaire consists of 40 items across five dimensions: emotional state, physical comfort, patient support, physical independence, and pain. Each item is rated on a five-point Likert scale, and the total score ranges from 40 to 200. Higher scores indicate better postoperative physical and emotional well-being, whereas lower scores indicate poorer quality of recovery. In this study, the QoR-40 will be used to assess quality of recovery in patients undergoing abdominal surgery at the end of weeks 3 and 6 after hospital discharge to evaluate the effect of Baduanjin exercise on postoperative recovery.

At the end of weeks 3 and 6 after hospital discharge.

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Collaborateurs

Les enquêteurs

  • Directeur d'études: Nurşen Kulakaç, Assoc. Prof., Gümüşhane Universıty

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

30 octobre 2026

Achèvement primaire (Estimé)

20 décembre 2026

Achèvement de l'étude (Estimé)

20 décembre 2026

Dates d'inscription aux études

Première soumission

24 octobre 2026

Première soumission répondant aux critères de contrôle qualité

24 octobre 2026

Première publication (Réel)

30 octobre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

9 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

3 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • NCNK

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner